Despite a dicey market we are staring down a full calendar this week and next. There are 13 deals in active marketing now which is pretty good (the system peaks out at around 20 or so because things are still manual, managements doing meetings, etc.)

Of the six scheduled for this week five are in the healthcare area, mostly in biotechnology. (Edge Therapeutics, NovoCure, Oasmia, Strongbridge in biotech and Surgery Partners which is a service provider.)

Performance Food Group (PFGC) is a big one with lots of underwriters. As a $13B foodservice distribution company it’s pretty boring but a nice stable option for some investors. Word is the deal is in great shape. Worthy of a trade if you can get IPO shares and enjoy that kind of thing… 

We’re taking a deeper look at CytomX which is scheduled for next week. But in the meantime what’s coming up right now? Here’s our list for this week in the order of attractiveness based on science and market opportunity: